|
Isoflavone contents in soy preparations used in this study. |
|||
| Daidzin |
Genistin |
Total1 |
|
|
|
|||
| Soy flour |
|||
| Mg/g |
0.62 ± 0.005 |
0.70 ± 0.01 |
1.32 ± 0.01 |
| % |
47 |
53 |
100 |
| Soy extract capsule |
|||
| Mg/capsule |
3.90 ± 0.04 |
11.29 ± 0.17 |
15.18 ± 0.21 |
| % |
26 |
74 |
100 |
|
1Summation of daidzin and genistin contents. | |||
Anupongsanugool et al. BMC Clinical Pharmacology 2005 5:2 doi:10.1186/1472-6904-5-2 |
|||